| Phase 2 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06623110 | Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease | High-Risk Oral Precancerous Disease | Recruiting | 2026-04-23 |
| NCT06805617 | A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland… | Salivary Gland Cancer | Recruiting | 2025-07-29 |
| NCT05010629 | 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma | Salivary Gland Cancer | Active, Not Recruiting | 2026-08-07 |